GRK2 and hydrops fetalis: Despite paroxetine’s ability to inhibit GRK2 as an off-target effect [147], its neurological side effects limit its use in HF therapy, driving researchers to design and develop selective small-molecule agents that inhibit GRK2 without these adverse effects.